The Last Word--For Now--On Dendreon
Since there should really be no compelling reason to blog or report on Dendreon and Provenge for quite awhile, here's one last hurrah. Someone named Lindy writes, "The obvious manipulation of this stock...makes me ill!" And Jack Truman thinks I'm partially to blame for that. He says, "(You) have been pumping all along...you should be ashamed of yourself...you guys have been pumping this pile of crap right into the ground."
My post yesterday on the contrast between press releases from Roche and Genentech about the very same thing drew a couple of comments from readers who disagreed with me. Spencer Guthrie who has an Elan email address and says he used to work at Genentech writes, "When you read those PRs (press releases), Roche's is written for the laymen, and Genentech's is written for the medical community. I think Genentech always takes the more scientific approach and that's why they have been so successful."
And an anonymous e-mailer says, "I really enjoy some of your insightful commentary/articles, however sometimes you take things to an absurd level. The Genentech/Biogen-Idec press release wasn't that difficult to interpret for investors and the medical community and perhaps the common lay person who is actually interested in treatment options...." DNA, by the way, kicks off the biopharma earnings season after the closing bell next Tuesday.
And my entry about Barack Obama's campaign getting a million bucks from the pharmaceuticals/health products industries prompted Neal Breitenbach to write, "I work for Pfizer and have given probably $1,000 to Obama's campaign (including the primary). I am certainly NOT (the caps are his) contributing to the Obama campaign because I work for big Pharma. I may or may not be affected by Obama policies as a Pharma employee, but will definitely be better off as a citizen with Obama as my President."
Neal's boss, PfizerChairman and CEO Jeff Kindler, was a fairly frequent contributor to Senator Hillary Clinton's campaign. According to the Center for Responsive Politics, Kindler gave the maximum $2,300 to Clinton three times since April of last year. His name does not come up when you search Kindlers who have contributed to Obama.
- Barack Obama: Big Pharma's Million Dollar Man
I'll be off for Yom Kippur and won't be blogging tomorrow. Before the holiday starts, though, I'll be seeing another hand specialist this afternoon because one month after my klutzy BlackBerry-related injury my finger is still very swollen, sore and inflexible. I'm not whining, just updating for anyone who cares or who might appreciate my cautionary tale about the dangers of walking and BlackBerrying. I still catch myself doing it and have to force myself to stand still.
Questions? Comments? Pharma@cnbc.com